These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 28956668)

  • 1. Biomarkers of diabetic nephropathy: A 2017 update.
    Papadopoulou-Marketou N; Kanaka-Gantenbein C; Marketos N; Chrousos GP; Papassotiriou I
    Crit Rev Clin Lab Sci; 2017 Aug; 54(5):326-342. PubMed ID: 28956668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic nephropathy in type 1 diabetes: a review of early natural history, pathogenesis, and diagnosis.
    Papadopoulou-Marketou N; Chrousos GP; Kanaka-Gantenbein C
    Diabetes Metab Res Rev; 2017 Feb; 33(2):. PubMed ID: 27457509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Markers of and risk factors for the development and progression of diabetic kidney disease.
    Macisaac RJ; Ekinci EI; Jerums G
    Am J Kidney Dis; 2014 Feb; 63(2 Suppl 2):S39-62. PubMed ID: 24461729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normoalbuminuric diabetic kidney disease.
    Chen C; Wang C; Hu C; Han Y; Zhao L; Zhu X; Xiao L; Sun L
    Front Med; 2017 Sep; 11(3):310-318. PubMed ID: 28721497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical predictive factors in diabetic kidney disease progression.
    Radcliffe NJ; Seah JM; Clarke M; MacIsaac RJ; Jerums G; Ekinci EI
    J Diabetes Investig; 2017 Jan; 8(1):6-18. PubMed ID: 27181363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum and Urinary Progranulin in Diabetic Kidney Disease.
    Nicoletto BB; Krolikowski TC; Crispim D; Canani LH
    PLoS One; 2016; 11(10):e0165177. PubMed ID: 27776152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Puberty, pregnancy, gender and hormonal status--putative risk factors for diabetic nephropathy].
    Panduru NM; Chivu LI; Chivu RD; Bădărău IA; Albu DF; Fica S; Ion DA
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(1):32-41. PubMed ID: 21495293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic nephropathy: traditional to proteomic markers.
    Moresco RN; Sangoi MB; De Carvalho JA; Tatsch E; Bochi GV
    Clin Chim Acta; 2013 Jun; 421():17-30. PubMed ID: 23485645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update of pathophysiology and management of diabetic kidney disease.
    Lin YC; Chang YH; Yang SY; Wu KD; Chu TS
    J Formos Med Assoc; 2018 Aug; 117(8):662-675. PubMed ID: 29486908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of new biomarkers for the diagnosis of nephropathy associated with diabetes type 2.
    Żyłka A; Gala-Błądzińska A; Rybak K; Dumnicka P; Drożdż R; Kuśnierz-Cabala B
    Folia Med Cracov; 2015; 55(4):21-33. PubMed ID: 26867117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-2-microglobulin (B2M) expression in the urinary sediment correlates with clinical markers of kidney disease in patients with type 1 diabetes.
    Monteiro MB; Thieme K; Santos-Bezerra DP; Queiroz MS; Woronik V; Passarelli M; Machado UF; Giannella-Neto D; Oliveira-Souza M; Corrêa-Giannella ML
    Metabolism; 2016 Jun; 65(6):816-24. PubMed ID: 27173460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into the use of biomarkers of diabetic nephropathy.
    Jha JC; Jandeleit-Dahm KA; Cooper ME
    Adv Chronic Kidney Dis; 2014 May; 21(3):318-26. PubMed ID: 24780461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic Nephropathy: An Overview.
    Sagoo MK; Gnudi L
    Methods Mol Biol; 2020; 2067():3-7. PubMed ID: 31701441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diabetic nephropathy/diabetic kidney disease].
    Boucek P
    Vnitr Lek; 2013 Mar; 59(3):201-3. PubMed ID: 23713188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on Diabetic Kidney Disease (DKD): Focus on Non-Albuminuric DKD and Cardiovascular Risk.
    Scilletta S; Di Marco M; Miano N; Filippello A; Di Mauro S; Scamporrino A; Musmeci M; Coppolino G; Di Giacomo Barbagallo F; Bosco G; Scicali R; Piro S; Purrello F; Di Pino A
    Biomolecules; 2023 Apr; 13(5):. PubMed ID: 37238622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Early detection of diabetic nephropathy].
    Murussi M; Murussi N; Campagnolo N; Silveiro SP
    Arq Bras Endocrinol Metabol; 2008 Apr; 52(3):442-51. PubMed ID: 18506269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of hsa-miR-100-5p May Be a Protective Factor in the Early Stages of Nephropathy in Type 1 Diabetes Mellitus.
    Pinheiro AHG; Pereira BO; Silva LSD; Melo FTC; Souza ACCB; Leal VSG; Figueiredo PBB; Neto JFA; Santos MCD; Queiroz NNM; Felício KM; Ribeiro-Dos-Santos Â; Felício JS; Cavalcante GC
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Research status and prospect of novel biomarkers for diabetic kidney disease].
    Feng ST; Wang B; Liu BC
    Zhonghua Yi Xue Za Zhi; 2021 Mar; 101(10):691-694. PubMed ID: 33721945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic challenges of diabetic kidney disease.
    Vučić Lovrenčić M; Božičević S; Smirčić Duvnjak L
    Biochem Med (Zagreb); 2023 Oct; 33(3):030501. PubMed ID: 37545693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.